Title : Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib.

Pub. Date : 2017 Apr 15

PMID : 27702817






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The DNA-PK inhibitor, NU7441, induced resistance to rucaparib (P = 0.014) and HR function recovery in a BRCA1-defective cell line.Conclusions: This study has shown that NHEJ is defective in 40% of ovarian cancers, which is independent of HR function and associated with resistance to PARP inhibitors in ex vivo primary cultures. 8-dibenzothiophen-4-yl-2-morpholin-4-yl-chromen-4-one collagen type XI alpha 2 chain Homo sapiens